VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales

Core Insights - VivoSim Labs, Inc. has appointed Dr. Arumugham Raghunathan as Vice President of Global Sales to enhance commercial growth and partnerships in the biopharma sector, particularly focusing on liver and gastrointestinal toxicity solutions [1][2][3] Company Overview - VivoSim Labs, Inc. specializes in next-generation New Approach Methodologies (NAMs) for preclinical safety, utilizing three-dimensional human tissue models for liver and intestinal toxicology [7] - The company is based in San Diego, California, and aims to accelerate the adoption of human tissue models following regulatory changes favoring non-animal testing methods [7] Leadership and Strategy - Dr. Raghunathan is recognized for his ability to build consultative relationships and guide clients from pilot studies to large-scale deployments, particularly in safety assessment and decision-making [2][3] - Under his leadership, VivoSim will focus on enhancing customer engagement and delivering solutions that provide clearer insights into drug candidate toxicity, thereby improving decision-making processes [4][5] Market Demand and Services - There is a growing demand for human-relevant toxicity prediction tools, especially in the Boston area and along the East Coast, as drug development timelines shorten and modalities diversify [5] - VivoSim's services are designed to support various stakeholders, including biotech startups, large pharmaceutical companies, and academic institutions, by providing insights into liver and GI toxicity [6]